The 8.8 million shares in ServiceTitan's initial public offering (IPO) were priced at $71 each, above the anticipated range, ...

Both INLIF and OneConstruction Group opened for trading this week. The Chinese producer of industrial manipulator arms for injection molding ...

Deal volume in 2025 may more than double the figure seen in the depths of the post-pandemic drought, if the biggest expected ...

Rainmaker Securities managing director Greg Martin joins Asking for a Trend to discuss what it signals for the broader IPO market. "This is a stellar opening for ServiceTitan," Martin says ...

The US tech IPO market is blocked up by startups that are scared to go public. But if stocks are anything to go by, they have ...

Momentum in the IPO market is expected to pick up in 2025 with Wall Street forecasting more companies itching to go public this year. EquityZen Chief Strategy Officer Phil Haslett discusses several of ...

After Reddit’s successful Wall Street debut in March, there was a sense among market experts that the market for tech initial public offerings was finally ready in 2024 to bounce back after the ...

Unimech Aerospace IPO allotment status online check can be done through the websites of BSE and NSE along with the official portal of IPO registrar. Kfin Technologies is Unimech Aerospace IPO ...

The IPO of Anya Polytech & Fertilizers was open for bidding between December 26 and December 30, selling its shares in the price band of Rs 13-14 per share with a lot size of 10,000 shares.

The Edelweiss Recently Listed IPO Fund Regular Plan Growth has an AUM of 973.95 crores & has delivered CAGR of 23.54% in the last 5 years. The fund has an exit load of 2.00% and an expense ratio ...

Nonetheless, India saw a steady rise in the number of top Indian companies filing for IPO this month. IPOs filed by Western Carriers India, Bajaj Housing Finance were completed “This year ...

According to a prospectus on the IPO, Zenas ended the second quarter with around $184 million in cash and has earmarked most of the IPO proceeds for obexelimab's clinical trials programme ...